In this article, we will discuss Enasidenib and Geriatric Use. So, let’s get started.
No dosage adjustment is required for Enasidenib based on age. In the clinical study, 61% of 214 patients were aged 65 years or older, while 24% were older than 75 years. No overall differences in
effectiveness or safety were observed between patients aged 65 years or older and younger patients.